Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Upcoming SlideShare
Loading in …5
×

Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and Acquisitions

111 views

Published on

Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and AcquisitionsSummaryGBI Research, the leading business intelligence provider, has released its latest report, 'Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs,Top Pharma Companies and Key Mergers and Acquisitions' that provides key data, information and analysis of the major trends and issues affecting the Pharmaceutical market. The report provides a comprehensive insight into the history of Pharmaceutical Industry Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and Acquisitions, its uses, efficiency as well as their limitations. The report also provides a detailed analysis of Pharmaceutical Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and Acquisitions in terms of its market size, and the major market drivers and barriers.. The report also looks into Pharmaceutical drug pipeline along with analysis on the pipeline by indication, phase of development and geography of development.This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.ScopeThe scope of the report includes: - Detailed overview of pharmaceutical industry 2009-2010.- Annualized market data - Key market drivers and restraints, challenges and trends shaping the Pharmaceutical market- Pipeline analysis of the along with segmentation by indication, phase and geography- Competitive landscape analysis with competitive profiling of leading companies such as - Analysis of M&A deals from 2009-2010 along with segmentation by value geography and companiesReasons to buyThe report will enhance your decision making capability. It will allow you to- Develop better strategies pharmaceutical industry- Develop market-entry and market expansion strategies - Understand the factors shaping the Pharmaceutical industry market- Reinforce R&D pipeline - Identify the key players best positioned to take the advantage of the opportunities in the pharmaceutical market- Exploit partnership and acquisition opportunities by identifying the products that could fill the portfolio gaps.

  • Be the first to comment

  • Be the first to like this

Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and Acquisitions

  1. 1. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!Pharmaceutical Industry - 2010 Yearbook - Therapeutic MarketLandscape, Key Pipeline Drugs, Top Pharma Companies and KeyMergers and AcquisitionsPublished on December 2010 Report SummaryPharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and KeyMergers and AcquisitionsSummaryGBI Research, the leading business intelligence provider, has released its latest report, Pharmaceutical Industry - 2010 Yearbook -Therapeutic Market Landscape, Key Pipeline Drugs,Top Pharma Companies and Key Mergers and Acquisitions that provides keydata, information and analysis of the major trends and issues affecting the Pharmaceutical market. The report provides acomprehensive insight into the history of Pharmaceutical Industry Therapeutic Market Landscape, Key Pipeline Drugs, Top PharmaCompanies and Key Mergers and Acquisitions, its uses, efficiency as well as their limitations. The report also provides a detailedanalysis of Pharmaceutical Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers andAcquisitions in terms of its market size, and the major market drivers and barriers.. The report also looks into Pharmaceutical drugpipeline along with analysis on the pipeline by indication, phase of development and geography of development.This report is built using data and information sourced from proprietary databases, primary and secondary research and in-houseanalysis by GBI Researchs team of industry experts.ScopeThe scope of the report includes:- Detailed overview of pharmaceutical industry 2009-2010.- Annualized market data- Key market drivers and restraints, challenges and trends shaping the Pharmaceutical market- Pipeline analysis of the along with segmentation by indication, phase and geography- Competitive landscape analysis with competitive profiling of leading companies such as- Analysis of M&A deals from 2009-2010 along with segmentation by value geography and companiesReasons to buyThe report will enhance your decision making capability. It will allow you to- Develop better strategies pharmaceutical industry- Develop market-entry and market expansion strategies- Understand the factors shaping the Pharmaceutical industry market- Reinforce R&D pipeline- Identify the key players best positioned to take the advantage of the opportunities in the pharmaceutical market- Exploit partnership and acquisition opportunities by identifying the products that could fill the portfolio gaps.Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and Acquisitions (From Slideshare) Page 1/11
  2. 2. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email! Table of Content1 Table of Contents 41.1 List of Tables 91.2 List of Figures 102 Introduction 122.1 GBI Research Report Guidance 123 Global Pharmaceutical Market Overview 2009 133.1 Introduction 133.2 Total Sales Of Pharmaceutical Drugs In 2009 133.3 Market Share By Therapeutic Areas, 2009 143.4 Top Selling Drugs Of 2009 153.4.1 Lipitor (atorvastin) 153.4.2 Plavix (clopidrogel) 153.4.3 Nexium (esmoprazole) 153.4.4 Advair (fluticasone salmetrol) 153.4.5 Seroquel (quetiapine) 153.4.6 Diovan (valsartan) 153.4.7 Enbrel (etanercept) 153.4.8 Remicade (infliximab) 153.4.9 Crestor (rosuvastatin) 153.4.10 Zyprexa (olanzapine) 153.5 Key Patent Expirations Of Drugs In 2009 164 Key Therapeutic Landscape 174.1 Cardiovascular Disease Therapeutics 174.1.1 Drivers for Cardiovascular Therapeutics Market 184.1.2 Restraints For Cardiovascular Therapeutics Market 204.1.3 Merger And Acquisition Deals Landscape For Cardiovascular Therapeutics, 2009-2010 214.2 Respiratory Disease Therapeutics 234.2.1 Drivers For Respiratory Therapeutics Market 244.2.2 Restraints For Respiratory Therapeutics Market 254.2.3 Merger And Acquisition Deals Landscape For Respiratory Therapeutics, 2009-2010 264.3 Musculoskeletal Disorder Therapeutics 274.3.1 Drivers For Musculoskeletal Therapeutics Market 294.3.2 Restraints For Musculoskeletal Therapeutics Market 304.3.3 Merger And Acquisition Deals Landscape For Musculoskeletal Therapeutics, 2009-2010 304.4 Oncology Therapeutics 324.4.1 Drivers For Oncology Therapeutics Market 344.4.2 Restraints For Oncology Therapeutics Market 354.4.3 Merger And Acquisition Deals Landscape For Oncology, 2009-2010 364.5 Central Nervous System Therapeutics 384.5.1 Drivers For CNS Therapeutics Market 404.5.2 Restraints For CNS Therapeutics Market 414.5.3 Merger And Acquisition Deals Landscape For Central Nervous System (CNS) Therapeutics, 2009-2010 424.6 Autoimmune Disease Therapeutics 434.6.1 Drivers For Autoimmune Therapeutics Market 45Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and Acquisitions (From Slideshare) Page 2/11
  3. 3. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!4.6.2 Restraints for Autoimmune Therapeutics Market 464.6.3 Merger and Acquisition Deals Landscape for Autoimmune Diseases Therapeutics, 2009-2010 474.7 Gastrointestinal Disorder Therapeutics 484.7.1 Drivers For Gastrointestinal Therapeutics Market 504.7.2 Restraints For Gastrointestinal Therapeutics Market 514.7.3 Merger And Acquisition Deals Landscape For Gastrointestinal Therapeutics, 2009-2010 514.8 Dermatology Therapeutics 534.8.1 Drivers For Dermatology Therapeutics Market 554.8.2 Restraints For Dermatology Therapeutics Market 564.8.3 Merger And Acquisition Deals Landscape For Dermatology Therapeutics, 2009-2010 564.9 Opthalmology Therapeutics 574.9.1 Drivers For Ophthalmology Therapeutics Market 604.9.2 Restraints For Ophthalmology Therapeutics Market 604.9.3 Merger And Acquisition Deals Landscape For Ophthalmology Therapeutics, 2009-2010 614.10 Mens Health Therapeutics 624.10.1 Drivers for Mens Health Market 644.10.2 Restraints for Mens Health Market 654.10.3 Merger And Acquisition Deals Landscape For Mens Health Therapeutics, 2009-2010 654.11 Womens Health Therapeutics 664.11.1 Drivers For Womens Health Market 684.11.2 Restraints For Womens Health Market 694.11.3 Merger And Acquisition Deals Landscape For Womens Health Therapeutics, 2009-2010 694.12 Blood Disorders Therapeutics 704.12.1 Drivers For Blood Disorders Therapeutics 724.12.2 Restraints For Blood Disorders Therapeutics 734.12.3 Merger And Acquisition Deals Landscape For Blood Disorders Therapeutics Market, 2009-2010 744.13 Urological Therapeutics Market 764.13.1 Drivers For Urology Therapeutics 784.13.2 Restraints for Urology Therapeutics Market 794.13.3 Merger And Acquisition Deals Landscape For Urology Therapeutics, 2009-2010 805 Key Promising Drugs In The Pipeline 825.1 Cardiovascular Therapeutics 825.1.1 Tekturna/Rasilez (acute heart failure) 825.1.2 Lixivaptan (acute heart failure) 835.1.3 Relaxin (acute heart failure) 835.1.4 Cinaciguat (acute heart failure) 845.1.5 Xarelto (atrial fibrillation) 855.1.6 Pradaxa (atrial fibrillation) 865.1.7 Stedicor (atrial fibrillation) 865.1.8 Kynapid (atrial fibrillation) 875.1.9 Edoxaban (atrial fibrillation) 885.2 Respiratory Therapeutics 895.2.1 Flutiform (fluticasone propionate/formoterol fumarate inhalation aerosol) (asthma) 895.2.2 MFF 258 (Mometasone furoate/formoterol fumarate) (asthma) 905.2.3 Aclidinium bromide (Chronic Obstructive Pulmonary Disease-COPD) 915.2.4 GW642444 (444) (COPD) 925.2.5 Iloprost (Pulmonary Arterial Hypertension) 935.2.6 ACT-064992 (Pulmonary Arterial Hypertension) 93Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and Acquisitions (From Slideshare) Page 3/11
  4. 4. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!5.2.7 Denufosol Tetrasodium Inhalation Solution (INS37217) (Cystic Fibrosis) 945.2.8 VX-770 (Cystic Fibrosis) 955.3 Musculoskeletal Disorder Therapeutics 965.3.1 Catena/Sovrima (Idebenone) 965.3.2 IPlex(TM) (mecasermin rinfabate) 965.3.3 CG5503 975.3.4 Vicodin CR 975.3.5 T-614 (iguratimod) 985.4 Oncology Therapeutics 995.4.1 Provenge (sipuleucel-T) 995.4.2 Gemzar (gemcitabine hydrochloride) 1005.4.3 Aflibercept 1015.4.4 Recentin (Cediranib) 1015.5 Central Nervous System (CNS) Therapeutics 1025.5.1 Staccato Loxapine, AZ-004 (Loxapine) 1025.5.2 Lurasidone 1035.5.3 Clonicel 1035.5.4 ABT-089 (Pozanicline) 1045.5.5 Safinamide 1055.5.6 Pimavanserin 1065.5.7 Stedesa (Eslicarbazepine Acetate) 1065.5.8 Comfyde (Carisbamate) 1075.6 Autoimmune Disease Therapeutics 1095.6.1 Benlysta (belimumab) 1095.6.2 Voclosporin (LX211, LUVENIQ, ISA-247) 1105.6.3 T-614 (iguratimod) 1115.6.4 Prograf (Tacrolimus) 1125.6.5 Mylinax (Cladribine Oral Formulation) 1135.7 Gastrointestinal Disorder Therapeutics 1145.7.1 Myoconda (For Crohns Disease) 1145.7.2 Traficet-EN (CCX282) (For Crohns Disease) 1155.7.3 Linaclotide (Linaclotide Acetate) (For Irritable Bowel Syndrome) 1165.7.4 Asimadoline (For Irritable Bowel Syndrome) 1175.7.5 XP19986 (For GERD) 1185.7.6 AZD3355 (For GERD) 1195.7.7 Prograf (Tacrolimus) (For Ulcerative Colitis) 1205.7.8 Vedolizumab (For Ulcerative Colitis) 1215.8 Dermatology Therapeutics 1215.8.1 Voclosporin (LX211, LUVENIQ, ISA-247) 1215.8.2 ABT-874 (J-695, Briakinumab) 1215.8.3 CF-101 1225.8.4 Orencia (abatacept, CTLA4-Ig, BMS-188667) 1225.8.5 Cimzia (CDP870 certolizumab pegol) 1225.8.6 Apremilast (CC10004, ACR20) 1225.8.7 INCB18424 1225.8.8 PH-10 1225.8.9 Hivenyl 1225.8.10 TF002 123Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and Acquisitions (From Slideshare) Page 4/11
  5. 5. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!5.9 Opthalmology Therapeutics 1235.9.1 Saflutan (tafluprost) (For Glaucoma) 1235.9.2 Retaane (Macular Degeneration) 1245.9.3 Photrex (SnET2) (Macular Degeneration) 1245.9.4 Vekacia (cyclosporine A) (Allergic Conjunctivitis) 1255.9.5 FOV1101 (Prednisporin) (Allergic Conjunctivitis) 1265.10 Mens Health Therapeutics 1275.10.1 Avanafil (For Erectile Dysfunction) 1275.10.2 Zoraxel (For Erectile Dysfunction) 1285.11 Womens Health Therapeutics 1295.11.1 Visanne (For Endometriosis) 1295.11.2 Proellex (For Endometriosis) 1295.11.3 Viviant (bazedoxifene) (For Osteoporosis) 1305.12 Blood Disorders Therapeutics 1315.12.1 Hematide (peginesatide) (For Anemia) 1315.12.2 NecLip-rFVIIa (LongSeven) (For Hemophilia) 1325.13 Urological Disorders Therapeutics 1325.13.1 NX-1207 (For BPH) 1325.13.2 YM178 (For Urinary Incontinence) 1335.13.3 CXA-101(For UTI) 1346 Merger and Acquisition Deals Landscape, 2009-2010 1356.1 Key Mergers And Acquisitions Deals Of 2009 1376.1.1 Pfizer Completes Acquisition Of Wyeth 1376.1.2 Roche Acquires Genentech 1386.1.3 Merck Completed Merger With Schering Plough Corporation 1386.1.4 Abbott Acquires Solvay Pharmaceuticals 1396.1.5 GSK Acquired Stiefel Laboratories 1397 Major Pharmaceutical Companies 1407.1 Pfizer 1407.1.1 Annual Revenue 1407.1.2 Top Selling Drugs of Pfizer 1407.1.3 Key Pipeline Drugs Of Pfizer 1417.1.4 Merger And Acquisition Deals Landscape Of Pfizer 1427.2 Johnson and Johnson (J&J) 1437.2.1 Annual Revenue 1437.2.2 Top Selling Drugs of J&J 1437.2.3 Key Pipeline Drugs Of J&J 1447.2.4 Merger And Acquisition Deals Landscape Of J&J 1457.3 Roche 1467.3.1 Annual Revenue 1467.3.2 Top Selling Drugs Of Roche 1467.3.3 Key Pipeline Drugs Of Roche 1477.3.4 Merger And Acquisition Deals Landscpae Of Roche 1487.4 GlaxoSmithKline (GSK) 1487.4.1 Annual Revenue 1487.4.2 Top Selling Drugs Of GSK 1487.4.3 Key Pipeline Drugs Of GSK 1507.4.4 Merger And Acquisition Landscape Of GSK 150Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and Acquisitions (From Slideshare) Page 5/11
  6. 6. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!7.5 Novartis 1517.5.1 Annual Revenue 1517.5.2 Top Selling Drugs Of Novartis 1517.5.3 Key Pipeline Drugs Of Novartis 1527.5.4 Merger And Acquisition Deals Landscape Of Novartis 1537.6 Sanofi-Aventis 1537.6.1 Annual revenues 1537.6.2 Top Selling Drugs Of Sanofi-Aventis 1537.6.3 Key Pipeline Drugs Of Sanofi-Aventis 1557.6.4 Merger and Acquisition Deals Landscape of Sanofi-Aventis 1557.7 AstraZeneca 1567.7.1 Annual Revenue 1567.7.2 Top Selling Drugs 1567.7.3 Key Pipeline Drugs Of Astrazeneca 1587.7.4 Merger And Acquisition Deals Landscape Of Astrazeneca 1587.8 Abbott 1587.8.1 Annual Revenues 1587.8.2 Top Selling Drugs Of Abbott 1587.8.3 Key Pipeline Drugs Of Abbott 1597.8.4 Merger And Acquisition Deals Landscape Of Abbott 1597.9 Merck 1607.9.1 Annual Revenue 1607.9.2 Top Selling Drugs Of Merck 1607.9.3 Key Pipeline Drugs Of Merck 1617.9.4 Merger and Acquisition Deals Landscape of Merck 1617.10 Bayer HealthCare 1627.10.1 Annual Revenue 1627.10.2 Top Selling Drugs Of Bayer HealthCare 1627.10.3 Key Pipeline Products Of Bayer Healthcare 1637.10.4 Merger And Acquisition Deals Landscape Of Bayer 1638 Key Regulations In Pharmaceutical Industry In 2009 1648.1 Key Regulations in Us In 2009 1648.1.1 Biologic License Applications (BLAs) Approved By FDA In 2009 1648.1.2 New Molecular Entities (NMEs) Approved By FDA In 2009 1658.1.3 Key Drug Recalls In US 1668.1.4 Key Black Box Warnings issued by FDA in 2009 1678.2 Key Regulations In Europe In 2009 1698.2.1 Key Drug Approvals By European Medicines Agency (EMA) In 2009 1698.2.2 Key Drug Recall In EU 1708.3 Key Regulations In Japan In 2009 1708.3.1 Key New Drug Application (NDA) And Drug Approvals By Ministry Of Health, Labour And Welfare (MHLW) Of Japan in 20091709 Pharmaceutical Industry Yearbook 2010: Appendix 1729.1 Market Definitions 1729.2 Abbreviations 1729.3 Research Methodology 1739.3.1 Coverage 1739.3.2 Secondary Research 173Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and Acquisitions (From Slideshare) Page 6/11
  7. 7. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!9.3.3 Primary Research 1739.3.4 Forecasts 1749.4 Contact Us 1779.5 Disclaimer 1779.6 Sources 1771.1 List of TablesTable 1: Pharmaceutical Market, Major Drug Patent Expirations,Global, 2009 16Table 2: Top Selling Drugs of Pfizer, Sales Value ($m), 2009 140Table 3: Key Pipeline Drugs Of Pfizer, 2009 141Table 4: Top Selling Drugs of JNJ,Sales Value ($m), 2009 143Table 5: Key Pipeline Drugs of Johnson and Johnson, 2009 144Table 6: Top Selling Drugs of Roche, Sales Value ($m), 2009 146Table 7: Key Pipeline Drugs of Roche, 2009 147Table 8: Top Selling Drugs of GSK, Sales Value ($m), 2009 148Table 9: Key Pipeline Drugs of GSK, 2009 150Table 10: Top Selling Drugs of Novartis, Sales Value ($m), 2009 151Table 11: Key Pipeline Drugs Of Novartis, 2009 152Table 12: Top Selling Drugs of Sanofi-Aventis,Sales Value ($m), 2009 153Table 13: Key Pipeline drugs of Sanofi-Aventis, 2009 155Table 14: Top Selling Drugs of AstraZeneca, Sales Value ($m), 2009 156Table 15: Key Pipeline Drugs of AstraZeneca, 2009 158Table 16: Top Selling Drugs of Merck ,Sales Value ($m), 2009 160Table 17: Key Pipeline Drugs of Merck, 2009 161Table 18: Top Selling Drugs of Bayer HealthCare, Sales Value ($m), 2009 162Table 19: Key Pipeline Drugs of Bayer, 2009 163Table 20: BLAs Approved by FDA in 2009 164Table 21: NME Approved by FDA in 2009 165Table 22: Key Warning Letters by FDA to Pharmaceutical Companies, 2009 168Table 23: Key Drug Approvals by EMA in 2009 169Table 24: Key NDA and Drug Approvals by MHLW, Japan, 2009 1711.2List of FiguresFigure 1: Global Pharmaceutical Market, Market Share of Top Manufacturers(%), 2009 13Figure 2: Global Pharmaceutical Industry, Market Share by Therapeutic Area, Global, Sales Value(%), 2009 14Figure 3: Cardiovascular Therapeutics Market, Global, Market Share of Top Manufacturers, 2009 17Figure 4: Cardiovascular Therapeutics ,Global, Market Share by Indication(%), 2009 and 2016 18Figure 5: Cardiovascular Therapeutics Market, Global, Market Drivers and Restraints, 2009-2010 18Figure 6: Cardiovascular Therapeutics Market,Global, M&A Deals by Geography, 2009 -2010 21Figure 7: Cardiovascular Therapeutics Market,Global, M&A Deals by Value ($), 2009-2010 22Figure 8: Respiratory Therapeutics Market, Global, Market Share of Top Manufacturers (%), 2009 23Figure 9: Respiratory Therapeutics ,Global, Market Share by Indication(%), 2009 and 2016 24Figure 10: Respiratory Therapeutics Market, Global, Market Drivers and Restraints, 2009-2010 24Figure 11: Respiratory Therapeutics Market, Global, M&A Deals by Geography, 2009-2010 26Figure 12: Respiratory Therapeutics Market, Global, M&A Deals by Value($), 2009-2010 26Figure 13: Musculoskeletal Disorder Therapeutics Market, Global, Market Share of Top Manufacturers, 2009 28Figure 14: Musculoskeletal Therapeutics , Market Share by Indication,Global, 2009 and 2016 29Figure 15: Musculoskeletal Disorder Therapeutics Market, Global, Drivers and Restraints, 2009-2010 29Figure 16: Musculoskeletal Therapeutics Market, Global, M&A Deals by Geography (2009-2010) 31Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and Acquisitions (From Slideshare) Page 7/11
  8. 8. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!Figure 17: Musculoskeletal Therapeutics Market, Global, M&A Deals by Value ($), 2009-2010 32Figure 18: Oncology Therapeutics Market, Global, Market Share of Top Manufacturers(%), 2009 33Figure 19: Global Oncology Market, Global, Market Share by Indication (%), 2009 and 2016 33Figure 20: Oncology Therapeutics Market, Global, Market Drivers and Restraints, 2009-2010 34Figure 21: Oncology Therapeutics Market, Global, M&A Deals by Geography, 2009-2010 36Figure 22: Oncology Therapeutics Market, Global, M&A Deals by Value ($), 2009-2010 37Figure 23: CNS Therapeutics Market, Global, Market Share of Top Manufacturers (%), 2009 38Figure 24: CNS Therapeutics Market, Global, Market Share by Indication (%), 2009 and 2016 39Figure 25: CNS Therapeutics Market, Global, Market Drivers and Restraints, 2009-2010 40Figure 26: CNS Therapeutics Market, Global, M&A Deals by Geography, 2009-2010 42Figure 27: CNS Therapeutics Market, Global, M&A Deals by Value ($), 2009 43Figure 28: Autoimmune Disease Therapeutics Market, Global, Market Share of Top Manufacturers(%), 2009-2010 44Figure 29: Autoimmune Disorders Market, Global, Sales by Indication (%), 2009 and 2016 45Figure 30: Autoimmune Disease Therapeutics Market, Global, Market Drivers and Restraints, 2009 45Figure 31: Autoimmune Disease Therapeutics Market, Global ,M&A Deals by Geography,2009 47Figure 32: Autoimmune Disease Therapeutics Market, Global ,M&A Deals by Value($), 2009 48Figure 33: Gastrointestinal Therapeutics Market, Market Share of Top Manufacturers (%), 2009 49Figure 34: Gastrointestinal Therapeutics Market, Global, Sales by Indication (%), 2009 and 2016 49Figure 35: Gastrointestinal Therapeutics Market, Global, Market Drivers and Restraints, 2009-2010 50Figure 36:Gastrointestinal Disorder Therapeutics Market, Global, M&A Deals by Geography, 2009 52Figure 37:Gastrointestinal Disorder Therapeutics Market, Global, M&A Deals by Value ($), 2009 52Figure 38: Dermatology Therapeutics Market, Global, Market Share of Top Manufacturers, 2009 53Figure 39: Dermatology Therapeutics Market, Global, Market Share by Indication (%), 2009 and 2016 54Figure 40: Dermatology Therapeutics Market, Global, Market Drivers and Restraints, 2009-2010 55Figure 41: Dermatology Therapeutics Market , Global, M&A Deals by Geography, 2009-2010 56Figure 42: Dermatology Therapeutics Market , Global, M&A Deals by Value ($), 2009 57Figure 43: Ophthalmology Therapeutics Market, Global, Market Share of Top Manufacturers (%), 2009 58Figure 44: Ophthalmology Therapeutics Market, Global, Sales by Indication (%), 2009 and 2016 59Figure 45: Global Ophthalmology Therapeutics Market, Drivers and Restraints, 2009 60Figure 46: Ophthalmology Therapeutics Market, Global, M&A deals by Geography ($), 2009 61Figure 47: Ophthalmology Therapeutics Market, Global, M&A deals by Value ($), 2009 62Figure 48: Mens Health Market, Global, Market Share of Top Manufacturers(%), 2009 63Figure 49: Mens Health Market, Global, Sales by Indication (%), 2009 and 2016 63Figure 50: Mens Health Market, Global, Market Drivers and Restraints, 2009-2010 64Figure 51: Mens Health Market, Global, M&A Deals by Geography(%), 2009-2010 65Figure 52: Mens Health Market,Global, M&A Deals by Value,($), 2009-2010 66Figure 53: Womens Health Market, Global, Market Share of Top Manufacturers, 2009 67Figure 54: Womens Health Market, Global, Market Share by Indication (%), 2009 and 2016 67Figure 55: Womens Health Market, Global, Drivers and Restraints, 2009-2010 68Figure 56: Womens Health Market, Global, M&A Deals by Geography(%), 2009-2010 69Figure 57: Womens Health Market, Global, M&A Deals by Geography, ($), 2009-2010 70Figure 58: Blood Disorders Market, Global, Market Share of Top Manufacturers(%), 2009 71Figure 59: Blood Disorder Therapeutics Market, Global, Market Share by Indication (%), 2009 and 2016 71Figure 60: Blood Disorders Market, Global, Market Drivers and Restraints, 2009-2010 72Figure 61: Blood Disorders Market, Global, Major M&A Deals by Geography, (%), 2009-2010 74Figure 62: Blood Disorders Market, Global, M&A Deals by Value, ($), 2009-2010 75Figure 63: Urological Disorders Market, Global, Market Share of Top Manufacturers(%), 2009 76Figure 64: Urological Therapeutics Market, Global, Sales by Indication (%), 2009 and 2016 77Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and Acquisitions (From Slideshare) Page 8/11
  9. 9. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!Figure 65: Urological Disorders Market, Global, Market Drivers and Restraints, 2009-2010 78Figure 66: Urological Disorders Market,Global, Major M&A Deals by Geography, 2009-2010 80Figure 67: Urological Disorders Market, Global, M&A Deals by Value($),2009-2010 81Figure 68: M&A Deals by Therapeutic Area, Global, Market Share(%), 2009-2010 135Figure 69: Major M&A Deals by Geography, Global, 2009-2010 136Figure 70: Major M&A Deals by Value($), Global, 2009-2010 137Figure 71: GBI Research Market Forecasting Methodology, 2010 176Companies mentionedPharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and Acquisitions (From Slideshare) Page 9/11
  10. 10. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email! Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93 If you have any questions please visit http://www.reportlinker.com/notify/contact Order Information Please verify that the product information is correct and select the format(s) you require. Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Compani es and Key Mergers and Acquisitions Product Formats Please select the product formats and the quantity you require. 1 User License--USD 3 500.00 Quantity: _____ Site License--USD 7 000.00 Quantity: _____ Corporate License--USD 10 500.00 Quantity: _____ Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: _____________________________ Last Name: __________________________________ Email Address: __________________________________________________________________________ Job Title: __________________________________________________________________________ Organization: __________________________________________________________________________ Address: __________________________________________________________________________ City: __________________________________________________________________________ Postal / Zip Code: __________________________________________________________________________ Country: __________________________________________________________________________ Phone Number: __________________________________________________________________________ Fax Number: __________________________________________________________________________Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and Acquisitions (From Slideshare) Page 10/11
  11. 11. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email! Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box. Payment by credit card Card Number: ______________________________________________ Expiry Date __________ / _________ CVV Number _____________________ Card Type (ex: Visa, Amex…) _________________________________ Payment by wire transfer Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189 Payment by check UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE Customer signature:   Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and Acquisitions (From Slideshare) Page 11/11

×